Loading...
Immune Therapy for Liver Cancers
Hepatocellular carcinoma (HCC) and biliary tract cancers (BTC) display a poor prognosis with 5-year overall survival rates around 15%, all stages taken together. These primary liver malignancies are often diagnosed at advanced stages where therapeutic options are limited. Recently, immune therapy ha...
Saved in:
| Published in: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7016834/ https://ncbi.nlm.nih.gov/pubmed/31892230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010077 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|